Consistent with our data on the profiles of protein factors, ELISA results showed that serum concentrations of LCN2 were higher in cachectic lung cancer patients than in non-cachectic lung cancer patients or healthy controls (Fig. 1C). This evidence concerns the gene LCN2 and lung carcinoma.